Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gaëlle Rousseau-Bussac"'
Autor:
Anne-Claire Toffart, Anne-Pascale Meert, Florent Wallet, Aude Gibelin, Olivier Guisset, Frédéric Gonzalez, Amélie Seguin, Achille Kouatchet, Myriam Delaunay, Didier Debieuvre, Boris Duchemann, Gaëlle Rousseau-Bussac, Martine Nyunga, David Grimaldi, Albrice Levrat, Elie Azoulay, Virginie Lemiale
Publikováno v:
Annals of Intensive Care, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Background Immune checkpoint inhibitors (ICI) have revolutionized the management of cancer. They can induce immune-related adverse events (irAE) leading to intensive care unit (ICU) admission. We aimed to describe irAEs for ICU admissions in
Externí odkaz:
https://doaj.org/article/959ab086f8e742cf93c8fac187f619e3
Autor:
Renaud Descourt, Maurice Pérol, Gaëlle Rousseau-Bussac, David Planchard, Bertrand Mennecier, Marie Wislez, Jacques Cadranel, Alexis Benjamin Cortot, Florian Guisier, Loïck Galland, Pascal Do, Roland Schott, Éric Dansin, Jennifer Arrondeau, Jean-Bernard Auliac, Margaux Geier, Christos Chouaïd
Publikováno v:
Cancers, Vol 14, Iss 7, p 1751 (2022)
Brigatinib is a next-generation ALK inhibitor (ALKi) that shows efficacy in ALK inhibitor naïve and post-crizotinib ALK+ advanced NSCLCs (aNSCLCs). The efficacy of brigatinib was retrospectively assessed in patients with aNSCLCs included in the brig
Externí odkaz:
https://doaj.org/article/ba90791955d34a7bbddfe74e2136a8ec
Publikováno v:
Bulletin du cancer. 99(11)
Palliative cares become an important element of the management of patients with lung cancer. The objective of this review is to review the literature data's of the impact of palliative cares in oncology, more particularly in thoracic oncology. The an